Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Nature ; 2023 Jun 09.
Article in English | MEDLINE | ID: covidwho-20238146
5.
Nature ; 615(7953):572-573, 2023.
Article in English | ProQuest Central | ID: covidwho-2267166

ABSTRACT

In particular, the National Science Foundation (NSF) would see its budget increase by nearly 19%, and the Department of Energy's Office of Science - a big investor in the physical sciences - would see an increase of nearly 9% (see 'Biden's budget requests for science in 2024'). "The public-health system has been so underfunded for so long that the truth of the matter is, it's going to take a fair amount of money to make that right, but it's a step in the right direction," he says. Furthermore, the budget would provide $24 billion to help US communities prepare for the rising impacts of climate change, and another $7 billion to help communities that depend on oil, gas and coal extraction to tran-sition to clean energy.

7.
Nature ; 2023 Jan 27.
Article in English | MEDLINE | ID: covidwho-2221785
11.
Nature ; 2022 Oct 31.
Article in English | MEDLINE | ID: covidwho-2096647
14.
Nature ; 604(7905): 230-231, 2022 04.
Article in English | MEDLINE | ID: covidwho-1795827
15.
Nature ; 604(7904): 18-19, 2022 04.
Article in English | MEDLINE | ID: covidwho-1783953
16.
Nature ; 2022 Feb 04.
Article in English | MEDLINE | ID: covidwho-1669051
17.
Nature ; 601(7894): 491-493, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1661950
18.
Nature ; 601(7894): 496, 2022 01.
Article in English | MEDLINE | ID: covidwho-1641925

Subject(s)
Antiviral Agents/therapeutic use , COVID-19 Drug Treatment , COVID-19/virology , Drug Development/trends , Drug Resistance, Viral , Research Personnel , SARS-CoV-2/drug effects , Adenosine Monophosphate/administration & dosage , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/pharmacology , Adenosine Monophosphate/therapeutic use , Administration, Oral , Alanine/administration & dosage , Alanine/analogs & derivatives , Alanine/pharmacology , Alanine/therapeutic use , Antiviral Agents/administration & dosage , Antiviral Agents/pharmacology , Antiviral Agents/supply & distribution , COVID-19/mortality , COVID-19/prevention & control , COVID-19 Vaccines/supply & distribution , Cytidine/administration & dosage , Cytidine/analogs & derivatives , Cytidine/pharmacology , Cytidine/therapeutic use , Drug Approval , Drug Combinations , Drug Resistance, Viral/drug effects , Drug Resistance, Viral/genetics , Drug Therapy, Combination , Hospitalization/statistics & numerical data , Humans , Hydroxylamines/administration & dosage , Hydroxylamines/pharmacology , Hydroxylamines/therapeutic use , Lactams/administration & dosage , Lactams/pharmacology , Lactams/therapeutic use , Leucine/administration & dosage , Leucine/pharmacology , Leucine/therapeutic use , Medication Adherence , Molecular Targeted Therapy , Mutagenesis , Nitriles/administration & dosage , Nitriles/pharmacology , Nitriles/therapeutic use , Proline/administration & dosage , Proline/pharmacology , Proline/therapeutic use , Public-Private Sector Partnerships/economics , Ritonavir/administration & dosage , Ritonavir/pharmacology , Ritonavir/therapeutic use , SARS-CoV-2/enzymology , SARS-CoV-2/genetics
19.
Nature ; 2022 Jan 19.
Article in English | MEDLINE | ID: covidwho-1628765
SELECTION OF CITATIONS
SEARCH DETAIL